The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens
Abstract
To better understand the difficulties surrounding the identification of novel antibacterial compounds from corporate screening collections, physical properties of ∼3200 antibacterial project compounds with whole cell activity against Gram-negative or Gram-positive pathogens were profiled and compared to actives found from high throughput (HTS) screens conducted on both biochemical and phenotypic bacterial targets. The output from 23 antibacterial HTS screens illustrated that when compared to the properties of the antibacterial project compounds, the HTS actives were significantly more hydrophobic than antibacterial project compounds (typically 2-4 log units higher), and furthermore, for 14/23 HTS screens, the average clogD was higher than the screening collection average (screening collection clogD = 2.45). It was found that the consequences of this were the following: (a) lead identification programs often further gained hydrophobic character with increased biochemical potency, making the separation even larger between the physicochemical properties of known antibacterial agents and the HTS active starting point, (b) the probability of plasma protein binding and cytotoxicity are often increased, and (c) cell-based activity in Gram-negative bacteria was severely limited or, if present, demonstrated significant efflux. Our analysis illustrated that compounds least susceptible to efflux were those which were highly polar and small in MW or very large and typically zwitterionic. Hydrophobicity was often the dominant driver for HTS actives but, more often than not, precluded whole cell antibacterial activity. However, simply designing polar compounds was not sufficient for antibacterial activity and pointed to a lack of understanding of complex and specific bacterial penetration mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Chemistry and Biology of Roseophilin and the Prodigiosin Alkaloids: A Survey of the Last 2500 Years
Fürstner, A. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300582 · Cited by 827
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Hernandez, V., Crépin, T., Palencia, A., Cusack, S., Akama, T., Baker, S. J., Bu, W., Feng, L., Freund, Y. R., Liu, L., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02058-12 · Cited by 196
Challenges of antibacterial discovery revisited
Gwynn, M. N., Portnoy, A., Rittenhouse, S. F., & Payne, D. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05828.x · Cited by 193
Assessment of the Consistency of Medicinal Chemists in Reviewing Sets of Compounds
Lajiness, M. S., Maggiora, G. M., & Shanmugasundaram, V. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049740z · Cited by 143
Substrate Specificity within a Family of Outer Membrane Carboxylate Channels
Eren, E., Vijayaraghavan, J., Liu, J., Cheneke, B. R., Touw, D. S., Lepore, B. W., Indic, M., Movileanu, L., & van den Berg, B. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001242 · Cited by 132
Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design
Abdelraouf, K., Braggs, K. H., Yin, T., Truong, L. D., Hu, M., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-12 · Cited by 120
Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa
Tomaras, A. P., Crandon, J. L., McPherson, C. J., Banevicius, M. A., Finegan, S. M., Irvine, R. L., Brown, M. F., O'Donnell, J. P., & Nicolau, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00629-13 · Cited by 110
Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies
Greene, N., Aleo, M. D., Louise‐May, S., Price, D. A., & Will, Y. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.129 · Cited by 69
Species differences in drug plasma protein binding
Colclough, N., Ruston, L., Wood, J. M., & MacFaul, P. A. (2014) · MedChemComm · doi:10.1039/c4md00148f · Cited by 69
Jenkins, R. E., Yaseen, F. S., Monshi, M. M., Whitaker, P., Meng, X., Farrell, J., Hamlett, J., Sanderson, J. P., El-Ghaiesh, S. H., Peckham, D. G., et al. (2013) · Chemical Research in Toxicology · doi:10.1021/tx400124m · Cited by 63
Hill, P., Abibi, A., Albert, R., Andrews, B. M., Gagnon, M. M., Gao, N., Grebe, T. P., Hajec, L. I., Huang, J., Livchak, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400718n · Cited by 55
Self-citationMolecular Determinants of AcrB-Mediated Bacterial Efflux Implications for Drug Discovery
Manchester, J. I., Buurman, E. T., Bisacchi, G. S., & McLaughlin, R. E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201275d · Cited by 54
Barker, C. A., Allison, S. E., Zlitni, S., Nguyen, N. D., Das, R., Melacini, G., Capretta, A. A., & Brown, E. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.005 · Cited by 41
Buurman, E. T., Andrews, B. M., Gao, N., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274068 · Cited by 41
Shahul Hameed, P., Manjrekar, P., Chinnapattu, M., Humnabadkar, V., Shanbhag, G., Kedari, C. K., Mudugal, N. V., Ambady, A., DeJonge, B. L. M., Sadler, C., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500360c · Cited by 25
Chapter 31 Plasma Protein Binding and the Free Drug Principle: Recent Developments and Applications
Trainor, G. L. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42031-0 · Cited by 10
Cited by
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Richter, M. F., Drown, B. S., Riley, A. P., Garcia, A., Shirai, T., Svec, R. L., & Hergenrother, P. J. (2017) · Nature · doi:10.1038/nature22308 · Cited by 891
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Self-citationOptimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Metadata
- Authors
- Brown, D. G., May-Dracka, T. L., Gagnon, M. M., & Tommasi, R.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-12-02
- Volume
- 57
- Issue
- 23
- Pages
- 10144-10161
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2054585308
- Cited by
- 253
- References
- 23
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.